31 Oct 2000 : Column: 335W

Written Answers to Questions

Tuesday 31 October 2000

SOLICITOR-GENERAL

Racism

Mr. Bercow: To ask the Solicitor-General how many prosecutions there have been for incitement to racial hatred in each of the past three years; and what proportion of those prosecutions have led to convictions. [134530]

The Solicitor-General: In 1998 there was one prosecution for offences of incitement to racial hatred under Part III of the Public Order Act 1986--this resulted in a conviction. In 1999 there were five defendants charged--three of these were convicted. There are currently three existing prosecutions involving such offences.

199719981999(1)2000
No consent applications12253
Withdrawn--1----
Not granted2------
Prosecuted10553
Convicted933(2)--

(1) To date

(2) Results awaited


HEALTH

Hospital Food

Mr. Bercow: To ask the Secretary of State for Health what assessment he has made of the quality of food in general hospitals in England and Wales. [134747]

Ms Stuart: Research has shown, and patients have told me, that in some hospitals the quality of food is not up to the standard that patients expect. The NHS Plan sets out a programme of work to improve the standard of hospital food:





31 Oct 2000 : Column: 336W

Patient environment action teams, comprising NHS professionals and patient representatives, are now visiting all acute hospitals as part of my initiative to improve the environment for patients, this includes looking at food services and seeking views from patients.

Work is progressing on all elements of this programme.

Drug-related Illnesses

Mr. Bercow: To ask the Secretary of State for Health what the estimated annual cost is to the NHS of treating people with drug-related illnesses. [134746]

Ms Stuart: In 1999-2000, the drug misuse special allocation to health authorities for the treatment of drug misuse was £59 million. Local authorities received £3 million through the drug and alcohol special grant for the same purpose. However, through the drug action team templates, health and local authorities report actual expenditure in excess of these levels. In 1998-99, the template indicated that £150.7 million was spent on drugs misuse treatment, inclusive of the special allocation and grant.

Beta Interferon

Mr. Field: To ask the Secretary of State for Health (1) when he next plans to meet the Chairman and members of the National Institute for Clinical Excellence to discuss their decision on not prescribing beta interferon; [134751]

Mr. Denham: The National Institute for Clinical Excellence has not yet published its final guidance on beta interferon for the treatment of multiple sclerosis and it would not be appropriate to pre-empt what the final guidance might say.

Mr. Field: To ask the Secretary of State for Health if he will estimate the savings in social security benefits and local authority care costs that would arise if beta interferon were prescribed to those patients who might benefit. [134739]

Mr. Denham: No. The National Institute for Clinical Excellence is conducting a thorough appraisal on beta interferon for the treatment of multiple sclerosis and has not yet completed its work.

Aricept

Dr. Cable: To ask the Secretary of State for Health what steps he is taking to ensure that Aricept and related drugs may be prescribed for Alzheimer's disease. [135063]

Mr. Denham: We have asked the National Institute for Clinical Excellence (NICE) to conduct an appraisal of Aricept and other related drugs for the treatment of Alzheimer's disease. We expect NICE to issue guidance in December 2000.

31 Oct 2000 : Column: 337W

Correspondence

Sir Brian Mawhinney: To ask the Secretary of State for Health when the right hon. Member for North-West Cambridgeshire will receive a reply to his letter of 16 August on behalf of his constituent Mrs. Sturman. [135791]

Ms Stuart [holding answer 30 October 2000]: A letter was sent to the right hon. Member on 30 October.

Mr. Winnick: To ask the Secretary of State for Health when the hon. Member for Walsall, North will receive a reply to his letter of 18 September regarding a constituent (reference POH(4)5608/55). [135456]

Ms Stuart [holding answer 30 October 2000]: A reply was sent to my hon. Friend on 27 October.

Mr. Winnick: To ask the Secretary of State for Health when the hon. Member for Walsall, North will receive a reply to his letter of 29 August (reference POH(4)5608/52). [135458]

Ms Stuart [holding answer 30 October 2000]: A reply was sent to my hon. Friend on 30 October.

Intermediate Care

Mr. Swayne: To ask the Secretary of State for Health how his Department defines intermediate care. [135836]

Mr. Hutton: The term 'intermediate care' describes a range of multi disciplinary, multi agency services designed to promote independence and improve quality of care, particularly for older people. The aims of intermediate care are to:




Intermediate care encompasses a wide range of service models and can be provided in a range of settings. These services can be provided in community-based settings or in the people's own homes, but may also be provided in step-down facilities within acute hospitals. The most intensive forms of rehabilitation should typically be provided in hospital.

Infant Mortality Rates

Jackie Ballard: To ask the Secretary of State for Health what the infant mortality rates were in each of the last 10 years for (a) Taunton constituency and (b) Somerset health authority. [134314]

Miss Melanie Johnson: The information requested falls within the responsibility of the National Statistician. I have asked him to reply.

Letter from Len Cook to Jackie Ballard, dated 31 October 2000:


31 Oct 2000 : Column: 338W


Infant mortality numbers and rates for Somerset HA and Taunton parliamentary constituency, 1990-99

REGYR(1)NumberRate(2)
Somerset HA
1990346.1
1991254.4
1992285.0
1993325.8
1994325.9
1995173.2
1996224.2
1997244.5
1998254.7
1999234.6
Taunton constituency
199043.4
199175.7
199254.3
199354.3
199465.3
199532.8
199632.7
199711.0
199832.8
199977.1

(3) Registration year

(4) Per 1,000 live births



Next Section Index Home Page